Walker Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$589K Buy
4,666
+21
+0.5% +$2.77K 0.3% 65
2026
Q1
$647K Buy
4,645
+98
+2% +$13.7K 0.35% 56
2025
Q4
$558K Buy
4,547
+19
+0.4% +$2.31K 0.3% 58
2025
Q3
$503K Buy
4,528
+31
+0.7% +$3.52K 0.28% 66
2025
Q2
$499K Buy
4,497
+23
+0.5% +$2.45K 0.29% 59
2025
Q1
$501K Buy
4,474
+61
+1% +$6.29K 0.3% 56
2024
Q4
$408K Buy
4,413
+2
+0% +$180 0.25% 68
2024
Q3
$370K Buy
4,411
+20
+0.5% +$1.53K 0.23% 81
2024
Q2
$301K Sell
4,391
-372
-8% -$24.8K 0.2% 94
2024
Q1
$349K Buy
4,763
+165
+4% +$12.7K 0.23% 82
2023
Q4
$372K Buy
4,598
+844
+22% +$65.7K 0.27% 67
2023
Q3
$281K Buy
3,754
+13
+0.3% +$1K 0.25% 64
2023
Q2
$288K Buy
3,741
+33
+0.9% +$2.63K 0.24% 67
2023
Q1
$308K Buy
3,708
+30
+0.8% +$2.48K 0.27% 57
2022
Q4
$316K Buy
3,678
+288
+8% +$22.8K 0.27% 53
2022
Q3
$209K Buy
3,390
+45
+1% +$2.84K 0.19% 72
2022
Q2
$207K Buy
+3,345
New +$207K 0.19% 85
2022
Q1
Sell
-3,202
Closed -$232K 94
2021
Q4
$232K Buy
+3,202
New +$221K 0.2% 72

Other funds holding GILD

Walker Asset Management's GILD Position: Q2 2026 in Review

Walker Asset Management increased its Gilead Sciences (GILD) stake by 0.45% in Q2 2026, buying an estimated $2.77K and bringing the position to 4,666 shares worth $589K. The position accounts for 0.3% of the portfolio, ranked #65.

Walker Asset Management first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $647K in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Walker Asset Management held 4,666 shares of Gilead Sciences worth $589K as of Q2 2026.
  • Walker Asset Management bought 21 Gilead Sciences shares in Q2 2026, an estimated $2.77K.
  • Gilead Sciences made up 0.3% of Walker Asset Management's portfolio in Q2 2026, its #65 holding.
  • Walker Asset Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • Walker Asset Management's Gilead Sciences position peaked at $647K in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Walker Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.